About 11 mil. left for trading 3-1/2 % are shorted What Type Of Shareholders Own The Most Number of CureVac N.V. (NASDAQ:CVAC) Shares? Simply Wall St Wed, June 9, 2021, 11:47 PM·4 min read
CVAC -3.47% The big shareholder groups in CureVac N.V. (NASDAQ:CVAC) have power over the company. Large companies usually have institutions as shareholders, and we usually see insiders owning shares in smaller companies. Warren Buffett said that he likes "a business with enduring competitive advantages that is run by able and owner-oriented people." So it's nice to see some insider ownership, because it may suggest that management is owner-oriented.
With a market capitalization of US$21b, CureVac is rather large. We'd expect to see institutional investors on the register. Companies of this size are usually well known to retail investors, too. Taking a look at our data on the ownership groups (below), it seems that institutions are noticeable on the share registry. Let's delve deeper into each type of owner, to discover more about CureVac.
View our latest analysis for CureVac
ownership-breakdown ownership-breakdown What Does The Institutional Ownership Tell Us About CureVac? Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.
As you can see, institutional investors have a fair amount of stake in CureVac. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see CureVac's historic earnings and revenue below, but keep in mind there's always more to the story.
earnings-and-revenue-growth earnings-and-revenue-growth CureVac is not owned by hedge funds. Looking at our data, we can see that the largest shareholder is dievini Hopp BioTech holding GmbH & Co. KG with 42% of shares outstanding. KfW, Asset Management Arm is the second largest shareholder owning 16% of common stock, and GlaxoSmithKline plc holds about 8.0% of the company stock.
Market Data 
Markets 
AI
